BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9844895)

  • 41. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G; Németh B
    Ther Hung; 1981; 29(3):120-3. PubMed ID: 7188137
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of cavinton in epilepsy].
    Dutov AA; Tolpyshev BA; Petrov AP; Gladun VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):850-5. PubMed ID: 3751419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Status of cerebral and central hemodynamics in patients with dyscirculatory encephalopathy].
    Voloshin PV; Pilipenko NI; Mishchenko TS; Voloshina RI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):15-9. PubMed ID: 3953186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 45. [The effect of local vibration on central and cerebral hemodynamics].
    Sova SH
    Lik Sprava; 1999; (3):68-71. PubMed ID: 10474940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cerebral circulation and various indices of the functional status of the brain during aging].
    Mints AIa; Litvinenko AA; Bachinskaia NIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1374-8. PubMed ID: 4072540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292
    [No Abstract]   [Full Text] [Related]  

  • 48. [The correction of microcirculatory disorders in patients with circulatory encephalopathy].
    Vesel'skiĭ ISh; Sanik AV
    Vrach Delo; 1991 Jul; (7):85-7. PubMed ID: 1771847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of vinpotropile in chronic brain ishemia].
    Ivanova NE; Panuntsev VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):73-5. PubMed ID: 18689011
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prospects of using cavinton for treating Ménière's disease].
    Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
    Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
    [No Abstract]   [Full Text] [Related]  

  • 51. [Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia].
    Vaizova OE; Vengerovsky AI; Alifirova VM
    Eksp Klin Farmakol; 2011; 74(4):10-3. PubMed ID: 21678652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevention of ischemic stroke and conception of hemodynamic reserve].
    Shirokov EA; Simonenko VB; Vilenskiĭ BS
    Klin Med (Mosk); 1998; 76(3):26-8. PubMed ID: 9575743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cavinton treatment of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI; Ishchenko AM
    Vrach Delo; 1986 Apr; (4):51-4. PubMed ID: 3716339
    [No Abstract]   [Full Text] [Related]  

  • 54. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
    Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [10-year experience with using Cavinton in cerebrovascular disorders].
    Burtsev EM; Savkov VS; Shprakh VV; Burtsev ME
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):56-60. PubMed ID: 1319651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia].
    Doronin BM; Popova TF; Kornach NV; Klimova LA; Volkova II; Chelysheva LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):48-50. PubMed ID: 19253466
    [No Abstract]   [Full Text] [Related]  

  • 58. [Characteristics of the action of strophanthin on central hemodynamics, pulmonary and intrahepatic blood circulation and myocardial contraction].
    Zavolovskaia LI
    Ter Arkh; 1985; 57(3):115-7. PubMed ID: 4002150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cerebrolysin in treatment of acute ischemic stroke].
    Domzał T; Zaleska B
    Neurol Neurochir Pol; 1995; 29(3):325-31. PubMed ID: 7566407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cardiogenic disorders of the systemic hemodynamics in lesions of the major cerebral arteries].
    Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
    Vrach Delo; 1991 Aug; (8):57-60. PubMed ID: 1949736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.